Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse

Journal of Oral Pathology and Medicine

Volumn 39, Issue 2, 2010, Pages 141-148

  Lohe, Vidya K ^a   Degwekar, Shirish S ^a   Bhowate, Rahul R ^a   Kadu, Ravindra P ^a   Dangore, Suwarna B ^a  

^a DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Leukoplakia; Lipid profile; Oral cancer; Oral precancer; Oral submucous fibrosis; Tobacco abuse

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LEUKOPLAKIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; TOBACCO DEPENDENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ARECA; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; SMOKING; TOBACCO, SMOKELESS; TRIGLYCERIDES; YOUNG ADULT;

EID: 76249132700     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00828.x     Document Type: Article

References (22)

1. Lynch MA, Brightman VJ, Greenberg MS. Burket's oral medicine, diagnosis and treatment, 9th edn. Philadelphia: J. B. Lippincott Company, 1994 204 205.
2. Sleron A, Adamek M, Kawczk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med 2003 32: 330 336.
3. Cheng B, Rhodus NL, Williams BA, Griffin RJ. Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: a preliminary study. J Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 97: 465 470.
4. Schatzkin A, Hoover RN, Taylor PR, et al. Site specific analysis of total serum cholesterol and incident cancers in the National health and nutrition examination survey I epidemiologic follow up study. Cancer Res 1988 48: 452 458.
5. Halton JM, Nazir DJ, Mcqueen MJ, Barr RD. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer 1998 83: 379 384.
6. Allampallam K, Dutt D, Nair C, et al. The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes. J Hematother Stem Cell Res 2000 9: 247 255.
7. Gerber M, Richardson S, De Paulet PC, Pujal H, De Paulet AC. Relationship between vitamin E and polyunsaturated fatty acids in breast cancer: nutritional and metabolic aspects. Cancer 1989 64: 2347 2353.
8. Gerber M, Cavallo F, Mrubini E, et al. Liposoluble vitamins and lipid parameters in breast cancer. A joint study in Northern Italy and Southern France. Int J Cancer 1988 42: 89 94.
9. Forones NM, Falcao JB, Mattos D, Barone B. Cholesterolemia in colorectal cancer. Hepatogastroenterology 1998 45: 1531 1534.
10. Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987 60: 3065 3070.
11. Patel PS, Shah MH, Jha FP, et al. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer 2004 41: 25 31.
12. Gilbert MS, Ginsberg H, Fagerstrom R, Brown WV. Characterization of hypocholesterolemia in myeloproliferative disease: relation of disease manifestations and activity. Am J Med 1981 71: 595 602.
13. Budd D, Ginsberg H. Hypocholesterolemia in acute myelogenous leukemia. Association between disease activity and plasma low density lipoprotein cholesterol concentrations. Cancer 1986 58: 1361 1365.
14. Chou PH, Noruma AM, Stemmermann GN, Kato I. Prospective study of serum cholesterol and site specific cancers. J Clin Epidemiol 1992 45: 287 292.
15. Larking PW. Cancer and low level of plasma cholesterol: the relevance of cholesterol precursors and products to incidence of cancer. Prev Med 1999 29: 383 390.
16. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. J Am Med Assoc 1981 245: 247 252.
17. Cambein F, Ducimetiere P, Richard J. Total serum cholesterol and cancer mortality in a middle aged male population. Am J Epidemiol 1980 112: 388 394.
18. Rose G, Shipley MJ. Plasma lipids and mortality: a source of error. Lancet 1980 1: 523 526.
19. Kark JD, Smith AH, Hames CG. Serum retinol and the inverse relationship between serum cholesterol and cancer. Br Med J 1982 284: 152 154.
20. Brown MS, Kovanen PT, Goldstein JL. Regulation of plasma cholesterol by lipoprotein receptors. Science 1981 212: 628 635.
21. Ames BN. Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 1983 221: 1256 1264.
22. Neufeld EJ, Mietus SM, Beiser AS, Baker AL, Newburger JW. Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation 1997 96: 1403 1407.